Medical Biomimetics Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-


The global Medical Biomimetics Market is estimated to be valued at US$ 33.5 Bn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. 

Market Overview:

Medical biomimetics refers to materials, devices, and engineering solutions that are inspired by biological systems and processes. It includes areas like tissue engineering, regenerative medicine, and prosthetics. Advancements in biomimicry are helping enable tissue regeneration, which holds promise for treating a variety of complex medical conditions. 

Market key trends: 

One of the major trends in the medical biomimetics market is the growing application of biomimicry for enabling tissue regeneration. A number of biomimetic materials aim to facilitate natural regeneration of tissues like bone, skin, nerves, and blood vessels. For instance, biomimetic protein-based hydrogels are being studied for their ability to provide structural and biochemical cues similar to extracellular matrices that enable integration and vascularization of transplanted cells and tissues. This paves way for treatment of complex injuries and disorders requiring tissue replacement.

Read More @ https://www.coherentmarketinsights.com/market-insight/medical-biomimetics-market-3786

Segment Analysis

The global medical biomimetics market is segmented into soft biomaterials, hard biomaterials and various applications. Among these, the soft biomaterials segment dominated the global market in 2022 and accounted for more than 40% share of the global market. This is because soft biomaterials are extensively used to replicate soft tissues such as ligaments, tendons, muscles, and skin. Further, within soft biomaterials, hydrogels are witnessing higher adoption owing to their greater biocompatibility as compared to other synthetic materials. 

Key Takeaways

The global medical biomimetics market is expected to witness high growth, exhibiting CAGR of 6.5% over the forecast period, due to increasing demand for medical devices and implants replicating human body functions and structures. 

Regional analysis

North America dominated the global medical biomimetics market in 2022 and is expected to maintain its dominance over the forecast period. This is attributed to continuous technological advancements and higher healthcare spending compared to other regions. Asia Pacific is expected to witness the fastest growth over the forecast period supported by growing medical tourism industry and increased funding for R&D activities in countries such as India and China.

Key players

Key players operating in the medical biomimetics market are AVINENT Science and Technology, SynTouch Inc., Wright Medical Group N.V., EPS Vascular, Varian Medical Systems, Inc., Vandstorm, Inc. AVINENT Science and Technology specializes in development of medical devices and implants inspired by nature. SynTouch Inc. is a leader in development of prosthetic limbs replicating human tactile functions.

Comments

Post a Comment

Popular posts from this blog

Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

-
Image
There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds. Business Dynamics In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-...
Read more

Breast Pumps Market to Surpass US$ 1,211.6 Million with a CAGR of 4.6% by 2027

-
Image
A breast pump is a mechanical tool used by breastfeeding women to suction-extract their breast milk, which they then use to feed their newborn children. Both manually and electrically driven breast pumping equipment is available. Breast pumps are advantageous for working women, women with shorter gestational periods, and women who give birth to multiples since they are unable to simultaneously breastfeed all of the babies, therefore they prefer a breast pump. Breast pumps aid in meeting the nutritional needs of babies of working mothers who do not want to sacrifice their development and growth since they are not constantly present with their infants. Business Dynamics Launches of breast pumps by leading industry players are anticipated to fuel the market's expansion throughout the forecast period. For instance, Sonata, the first smart breast pump to give hospital-level performance in a personal use breast pump, was introduced by Madela, Inc. in November 2016. This breast pump conn...
Read more

Angioedema Treatment Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2024 To 2031

-
Image
Introduction: Angioedema, a condition characterized by rapid swelling of deeper layers of the skin and mucous membranes, poses a significant health concern for affected individuals. The Angioedema Treatment Market has been witnessing notable advancements, providing a ray of hope for patients grappling with this often unpredictable and potentially life-threatening condition. Market Dynamics: The Angioedema Treatment Market has experienced a paradigm shift in recent years, driven by increased awareness, improved diagnostic capabilities, and a surge in research and development efforts. Angioedema can be hereditary or acquired, and the market is witnessing a growing prevalence of both forms, necessitating a diversified approach to treatment options. Treatment Modalities: Therapeutic approaches to Angioedema have evolved, offering a range of options for patients. Antihistamines and corticosteroids are commonly prescribed for acute cases, providing relief from swelling and discomfort. In mor...
Read more